This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Boehringer Ingelheim International Gmbh, Novartis Ag. Active years: 2013-2014.
Company Filing History:
Years Active: 2013-2014
Title: The Innovative Contributions of Alessandro Mazzacani
Introduction
Alessandro Mazzacani is a notable inventor based in Brighton, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with valuable pharmacological properties. His work has implications for the treatment of various cardiovascular disorders and diseases mediated by the ghrelin receptor.
Latest Patents
Mazzacani holds 2 patents that showcase his innovative approach to drug development. His latest patents include "Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation." This invention focuses on compounds of formula (I), which possess valuable pharmacological properties, making them useful for treating cardiovascular and related disorders. Another significant patent is for "3-spirocyclic piperidine derivatives as ghrelin receptor agonists." This invention relates to derivatives of formula (I) and includes processes for their preparation, pharmaceutical compositions, and their use as medicaments for treating disorders mediated by the ghrelin receptor.
Career Highlights
Throughout his career, Mazzacani has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to contribute to the advancement of medicinal compounds and their applications in healthcare.
Collaborations
Mazzacani has collaborated with several professionals in his field, including Ameet Vijay Ambarkhane and Gurdip Bhalay. These collaborations have further enriched his research and development efforts.
Conclusion
Alessandro Mazzacani's innovative work in medicinal chemistry and his contributions to the development of pharmacologically valuable compounds highlight his importance as an inventor. His patents reflect a commitment to advancing healthcare solutions, particularly in treating cardiovascular disorders and related diseases.